Eastman Chemical SVP granted 7,280 EMN shares

Eastman Chemical executive Julie A. McAlindon reported an equity award of company stock.

Accepted by SEC EDGAR 02/13/2026 - 04:02 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Eastman Chemical executive Julie A. McAlindon reported an equity award of company stock. On February 11, 2026, she acquired 7,280 shares of Eastman Chemical common stock at a price of $0 per share, reported as a grant, award, or other acquisition.

The footnote explains this reflects the determination of performance shares earned for the three-year 2023–2025 performance period, meaning the award was tied to multi‑year performance goals. After this grant, McAlindon directly beneficially owned 20,011 common shares, and indirectly beneficially owned an additional 887 shares through an ESOP.

Insider Trade Summary

Grant/Award: 7,280 shares

Grant/Award 1 txn

Insider McAlindon Julie A.

Role SVP, Regions & Chf SupChn Ofcr

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,280	$0.00	$0.00
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 20,011 shares (Direct); Common Stock — 887 shares (Indirect, By ESOP)

Holdings Before and After: Common Stock, 12,731 to 20,011 shares (Direct)

Footnotes (1)

1. F1. Determination of the number of performance shares earned for the three-year (2023- 2025) performance period.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Eastman Chemical (EMN) report for Julie A. McAlindon?

Julie A. McAlindon reported acquiring 7,280 shares of Eastman Chemical common stock. The Form 4 describes this as a grant, award, or other acquisition, with no cash price paid, reflecting earned performance shares for a multi‑year period.

On what date did Julie A. McAlindon receive the Eastman Chemical (EMN) stock award?

The stock award to Julie A. McAlindon was effective on February 11, 2026. This date is listed as the transaction date for the acquisition of 7,280 common shares reported on the Form 4 insider trading report.

What was the price paid per share for Julie A. McAlindon’s Eastman Chemical (EMN) grant?

The 7,280 Eastman Chemical common shares were reported at a price of $0 per share. This indicates a compensatory grant or award rather than an open‑market purchase, consistent with performance-based equity compensation.

How many Eastman Chemical (EMN) shares does Julie A. McAlindon beneficially own after this Form 4?

After the reported grant, Julie A. McAlindon beneficially owns 20,011 Eastman Chemical shares directly. She also indirectly owns 887 additional common shares through an ESOP, as disclosed in the ownership table of the Form 4.

What performance period is tied to Julie A. McAlindon’s Eastman Chemical (EMN) share award?

The award reflects performance shares earned for the three‑year 2023–2025 performance period. A footnote explains the transaction represents the determination of the number of performance shares earned over that multi‑year timeframe.

What is Julie A. McAlindon’s role at Eastman Chemical (EMN) mentioned in the Form 4?

Julie A. McAlindon is identified as an officer of Eastman Chemical, serving as SVP, Regions & Chief Supply Chain Officer. Her role is disclosed in the relationship section of the Form 4 insider trading report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McAlindon Julie A.

(Last) (First) (Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Regions & Chf SupChn Ofcr

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		A		7,280(1)	A	$0	20,011	D
Common Stock								887	I	By ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Determination of the number of performance shares earned for the three-year (2023- 2025) performance period.

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Julie A. McAlindon	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.